Estimating the relative contributions of virulence factors for pathogenic microbes

Infection and Immunity

Volumn 74, Issue 3, 2006, Pages 1500-1504

  McClelland, Erin E ^a   Bernhardt, Paul ^b   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WESTMINSTER COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTIGEN; MELANIN; UREASE; VACCINE; VIRULENCE FACTOR;

ARTICLE; BACILLUS ANTHRACIS; CRYPTOCOCCUS NEOFORMANS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRULENCE;

ANALYSIS OF VARIANCE; BACILLUS ANTHRACIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; MODELS, THEORETICAL; VIRULENCE; VIRULENCE FACTORS;

EID: 33644757641     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.3.1500-1504.2006     Document Type: Article

References (26)

1. Andrade, S. A., D. N. Santos, A. C. Bastos, M. R. Pedromonico, N. de Almeida-Filho, and M. L. Barreto. 2005. Family environment and child's cognitive development: an epidemiological approach. Rev. Saude Publica 39:606-611. (In Portuguese.)
2. Bulmer, G. S., M. D. Sans, and C. M. Gunn. 1967. Cryptococcus neoformans. I. Nonencapsulated mutants. J. Bacteriol. 94:1475-1479.
3. Casadevall, A. 2005. Host as the variable: model hosts approach the immunological asymptote. Infect. Immun. 73:3829-3832.
4. Casadevall, A., and L. Pirofski. 2001. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184:337-344.
5. Casadevall, A., and L. A. Pirofski. 1999. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67:3703-3713.
6. Cox, G. M., H. C. McDade, S. C. Chen, S. C. Tucker, M. Gottfredsson, L. C. Wright, T. C. Sorrell, S. D. Leidich, A. Casadevall, M. A. Ghannoum, and J. R. Perfect. 2001. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39:166-175.
7. Cox, G. M., J. Mukherjee, G. T. Cole, A. Casadevall, and J. R. Perfect. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:443-448.
8. Demirbag, R., and R. Yilmaz. 2005. Effects of the shape of coronary arteries on the presence, extent, and severity of their disease. Heart Vessels 20:224-229.
9. Dziva, F., P. M. van Diemen, M. P. Stevens, A. J. Smith, and T. S. Wallis. 2004. Identification of Escherichia coli O157:H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis. Microbiology 150:3631-3645.
10. Green, S. B. 1991. How many subjects does it take to do a regression analysis? Multivar. Behav. Res. 26:499-510.
11. Hubálek, M., L. Hernychová, M. Brychta, J. Lenèo, J. Zechovská, and J. Stulik. 2004. Comparative proteome analysis of cellular proteins extracted from highly virulent Francisella tularensis ssp. tularensis and less virulent F. tularensis ssp. holarctica and F. tularensis ssp. mediaasiatica. Proteomics 4:3048-3060.
12. Kozel, T. R., G. S. Pfrommer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev. Infect. Dis. 10(Suppl. 2):S436-S439.
13. Kwon-Chung, K. J., and J. C. Rhodes. 1986. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:218-223.
14. Liu, L., R. P. Tewari, and P. R. Williamson. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
15. Maxwell, S. E. 2000. Sample size and multiple regression analysis. Psychol. Methods 5:434-458.
16. McClelland, E. E., W. T. Perrine, W. K. Potts, and A. Casadevall. 2005. The relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines. Infect. Immun. 73:7047-7050.
17. Miller, J. 2002. RandGen. A program for generating random numbers (version 1.2). http://psy.otago.ac.nz/miller/. University of Otago, Dunedin, New Zealand.
18. Nelson, R. T., J. Hua, B. Pryor, and J. K. Lodge. 2001. Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis. Genetics 157:935-947.
19. Nguyen, M. H., S. Cheng, and C. J. Clancy. 2004. Assessment of Candida albicans genes expressed during infections as a tool to understand pathogenesis. Med. Mycol. 42:293-304.
20. Potvin, E., D. E. Lehoux, I. Kukavica-Ibrulj, K. L. Richard, F. Sanschagrin, G. W. Lau, and R. C. Levesque. 2003. In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ. Microbiol. 5:1294-1308.
21. Poulin, R, and C. Combes. 1999. The concept of virulence: interpretations and implications. Parasitol. Today 15:474-475.
22. Salas, S. D., J. E. Bennett, K. J. Kwon-Chung, J. R. Perfect, and P. R. Williamson. 1996. Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:377-386.
23. Tabachnick, B. G., and L. S. Fidell. 2001. Using multivariate statistics, 4th ed. Allyn & Bacon, Boston, Mass.
24. Tariq, S. R., M. H. Shah, N. Shaheen, A. Khalique, S. Manzoor, and M. Jaffar. 2005. Multivariate analysis of trace metal levels in tannery effluents in relation to soil and water: a case study from Peshawar, Pakistan. J. Environ. Manag. doi:10.1016/j.jenvman.2005.05.009. [Epub ahead of print.]
25. Wang, P., G. M. Cox, and J. Heitman. 2004. A Sch9 protein kinase homologue controlling virulence independently of the cAMP pathway in Cryptococcus neoformans. Curr. Genet. 46:247-255.
26. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.